Clinical Trials Sponsored by Centocor BV

Total 419 results

Philips Electronics Nederland BV

Completed

Blue Light for Treating Psoriasis Vulgaris

Psoriasis Vulgaris

Germany
Univar BV
Aptiv Solutions

Completed

A Phase 1 Study to Assess the Effects in the Body of a Single Dose of Trientine Dihydrochloride in Wilson's Disease Patients

Wilson's Disease

Germany
Newtricious R&D BV

Completed

Effect of NWT-03 on Blood Pressure

Blood Pressure | Albuminuria

Ireland
Maastricht University Medical Center
SenterNovem; Newtricious BV; Globus Ei BV

Completed

The Effect of Eggs and Egg Products on Macular Pigment

Age-related Macular Degeneration

Netherlands
Merck Sharp & Dohme LLC
Centocor, Inc.

Terminated

Enthesitis With Ultra Sonography Doppler in Spondyloarthropathies Treated With Infliximab (Study P04440) (EUSpA)

Spondylitis, Ankylosing | SpA
Merck Sharp & Dohme LLC
Centocor, Inc.

Completed

Post Marketing Surveillance Study of Remicade in Patients With Chronic Inflammatory Diseases (P04840) (REMission)

Arthritis, Rheumatoid | Psoriasis | Crohn's Disease | Arthritis, Psoriatic | Spondylitis, Ankylosing
Merck Sharp & Dohme LLC
Centocor, Inc.

Completed

Investigation of 9 Consecutive Infusions of Remicade for Psoriatic Arthritis in Austria (Study P04264)

Arthritis, Psoriatic
Merck Sharp & Dohme LLC
Centocor, Inc.

Completed

Program Extension of Real Life Dosing of Remicade in Austria for Crohn's Disease (Study P04052)(COMPLETED)

Crohn's Disease
Merck Sharp & Dohme LLC
Centocor, Inc.

Completed

Investigation of 9 Consecutive Remicade Infusions in Ankylosing Spondylitis in Austria (Study P04044)(COMPLETED)

Spondylitis, Ankylosing
Cryotherapeutics SA
CoreAalst BV

Recruiting

Intracoronary Cryotherapy Effect on Stabilization of Vulnerable Plaque in Patients With NSTEMI or Unstable Angina (POLARSTAR)

Myocardial Infarction | Coronary Artery Disease | Cryotherapy Effect | Coronary Syndrome | Atherosclerosis, Coronary | Myocardial Disease

Lithuania, Georgia
Wageningen University
WholeFiber BV

Not yet recruiting

Impact of a Dried Vegetable on Bowel Function and Gut Microbiota

Bowel Function Dissatisfaction

Netherlands
Aesculape CRO Belgium BV

Recruiting

Study Evaluating the Efficacy and Safety of Miconazole Nitrate + Domiphen Bromide Vaginal Cream in the Treatment of Subjects With Acute Vulvovaginal Candidiasis

Acute Vulvovaginal Candidiasis

Belgium
Acerta Pharma BV
AstraZeneca

Active, not recruiting

Study of Acalabrutinib (ACP-196) in Combination With Venetoclax (ABT-199), With and Without Obinutuzumab (GA101) Versus Chemoimmunotherapy for Previously Untreated CLL (AMPLIFY)

Chronic Lymphocytic Leukemia

United States, Spain, Canada, Italy, Taiwan, Russian Federation, Turkey, Germany, Korea, Republic of, Brazil, Hungary, Poland, China, Sweden, Bulgaria, Israel, United Kingdom, Australia, Saudi Arabia, Austria, France, Czechia, South... and more
Acerta Pharma BV
AstraZeneca

Active, not recruiting

A Study of BR Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreated MCL

Lymphoma, Mantle Cell

United States, France, Italy, Taiwan, Mexico, Russian Federation, Vietnam, Belgium, Canada, Brazil, Hungary, Japan, Poland, China, Spain, Germany, Australia, Czechia, Korea, Republic of, Israel, Romania, Ukraine, Argentina, Peru, New Zealand and more
Acerta Pharma BV
AstraZeneca

Terminated

Acalabrutinib Study With Best Supportive Care in Participants Hospitalized With COVID-19

COVID-19

Brazil
AstraZeneca
Acerta Pharma BV

Completed

Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19. (CALAVI)

COVID-19

Italy, Turkey, Brazil, Japan, South Africa, Germany, Poland, Russian Federation, India, Peru, France, Argentina, Chile, Mexico
AstraZeneca
Acerta Pharma BV

Completed

Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19. (CALAVI US)

COVID-19

United States
Aeras
Crucell Holland BV

Completed

Safety and Immunogenicity of AERAS-402 in HIV-infected, Bacillus Calmette-Guerin (BCG)-Vaccinated Adults

HIV Infections | Tuberculosis

South Africa
Qvanteq AG
Cardialysis BV

Completed

Qvanteq Bioactive Coronary Stent System First in Man (FIM) Clinical Investigation

Coronary Artery Disease

Netherlands, Switzerland
Aeras
Crucell Holland BV

Completed

A Study to Evaluate the Safety of AERAS-402 in Adults Recently Treated for Pulmonary TB (C-010-402)

Tuberculosis

South Africa
Philips Electronics Nederland BV

Completed

Blue Light for Treating Eczema

Eczema

Germany
Synapse bv
Maastricht University

Completed

The Effect of Strenuous Exercise on Coagulation.

The Effect of Strenuous Exercise on Haemostasis.

Netherlands
Newtricious R&D BV

Completed

Effect of NWT-03 on Blood Pressure - Part 1

Blood Pressure
Merck Sharp & Dohme LLC
Centocor, Inc.

Completed

A Study to Evaluate the Switch From Etanercept to Infliximab in Subjects With Moderate-to-Severe Psoriasis (Study P05133) (TANGO)

Psoriasis
Connecticut Children's Medical Center
Centocor, Inc.

Completed

Pediatric Inflammatory Bowel Disease Collaborative Research Group Registry

Inflammatory Bowel Disease

United States, Canada
Merck Sharp & Dohme LLC
Centocor, Inc.

Completed

European Safety Registry in Ulcerative Colitis (P04808) (OPUS)

Ulcerative Colitis
M.D. Anderson Cancer Center
Centocor, Inc.

Completed

A Randomized Trial of Procrit vs. No Procrit in AML and High Risk MDS

Leukemia | Myelodysplastic Syndrome | Acute Myelogenous Leukemia

United States
Merck Sharp & Dohme LLC
Centocor, Inc.

Completed

Real Life Dosing of Remicade for Rheumatoid Arthritis in Austria Monitored Over 9 Infusions (Study P03756)(COMPLETED)

Rheumatoid Arthritis
Merck Sharp & Dohme LLC
Centocor, Inc.

Terminated

Impact of Infliximab in Fistulizing Crohn's Disease on Health Care Resources (Study P04204)(TERMINATED)

Crohn Disease
Columbia University
Centocor Research & Development, Inc.

Completed

Lupus Nephritis Biomarker Study: Baseline Characteristics of Patients

Lupus Nephritis

United States
Centocor, Inc.
Janssen-Cilag Farmaceutica, S.R.L.

Completed

A Safety and Efficacy Study of Intetumumab, Alone and in Combination With Dacarbazine, in Participants With Stage 4 Melanoma

Melanoma

United States, United Kingdom, Germany
Centocor, Inc.
Eli Lilly and Company

Terminated

A Study of Effectiveness and Safety of Abciximab in Patients With Acute Ischemic Stroke (AbESTT-II)

Brain Ischemia | Acute Disease | Cerebrovascular Accident
Dallas VA Medical Center
Centocor, Inc.

Unknown

Cardiovascular Outcomes in the VA's Rheumatoid Arthritis(VARA) Population

Coronary Disease | Cardiovascular Disease | Rheumatoid Arthritis

United States
Merck Sharp & Dohme LLC
Centocor, Inc.

Completed

A Study to Evaluate Infliximab in Subjects With Moderate-to-Severe Psoriasis Not Responding to Standard or Biologic Therapy (Study P04612) (ESAQUALITY)

Psoriasis
Merck Sharp & Dohme LLC
Centocor, Inc.

Completed

Study to Evaluate the Efficacy of Infliximab Induction Therapy for Patients With Palmoplantar Psoriasis (PPP)(Study P04555)(COMPLETED) (TIPS)

Psoriasis
Merck Sharp & Dohme LLC
Centocor, Inc.

Completed

Remicade Safety Line (Ankylosing Spondylitis)(Study P03275)(COMPLETED)

Spondylitis, Ankylosing
Merck Sharp & Dohme LLC
Centocor, Inc.

Completed

Remicade Safety Line (Crohn's Disease)(Study P03288)(COMPLETED)

Crohn's Disease
Merck Sharp & Dohme LLC
Centocor, Inc.

Completed

Five-Year Observation of Remicade Treatment for Plaque Psoriasis in Austria (Study P04900)

Psoriasis
Centocor, Inc.
Eli Lilly and Company

Completed

A Study of Abciximab and Reteplase When Administered Prior to Catherization After a Myocardial Infarction (Finesse)

Myocardial Infarction

United States, France, United Kingdom, Belgium, Germany, Spain, Poland, Bulgaria, Romania, Israel, Sweden, Canada, Czech Republic, Argentina, Austria, Denmark, Netherlands, South Africa, Switzerland
GATT Technologies BV
Syneos Health

Active, not recruiting

GATT-Patch Versus TachoSil in Liver Surgery

Liver Diseases | Intraoperative Bleeding | Hemorrhage, Surgical

United States, Netherlands, Germany
LiteVax BV
University Hospital, Ghent

Completed

Safety, Tolerability, and Immunogenicity of TETRALITE, a Novel Adjuvanted, Low-dose Influenza Vaccin (TETRALITE-I)

Influenza

Belgium
Boston Scientific Corporation
Cardialysis BV

Unknown

SYNTAX Study: TAXUS Drug-Eluting Stent Versus Coronary Artery Bypass Surgery for the Treatment of Narrowed Arteries (SYNTAX)

Coronary Artery Disease

United States, Italy, Latvia, Netherlands, United Kingdom, France, Spain, Sweden, Germany, Hungary, Poland, Portugal, Austria, Belgium, Norway, Czech Republic, Denmark, Finland
University Medical Center Groningen
University of Twente; Vivisol; Löwenstein BV; Sencure BV

Not yet recruiting

Improving Chronic Nocturnal Noninvasive Ventilation: a Multimodality Approach (NOCTIVENT)

Chronic Respiratory Failure | Non-invasive Ventilation
Aplagon Oy
TRACER Europe BV

Recruiting

Safety, Tolerability, and Biodistribution of [89Zr]Zr-DFO-APAC in Subjects With PAOD/CLI and Healthy Volunteers (Acronyms: 89Zr = Zirconium-89, DFO = Desferrioxamine, APAC = AntiPlatelet AntiCoagulant, PET/CT = Positron Emission Tomography/Computed Tomography) (CHASE)

Peripheral Arterial Occlusive Disease | Critical Limb Ischemia

Netherlands
Ziekenhuis Oost-Limburg
Synapse bv

Recruiting

COAgulation Disorders in Ischaemic and Haemorrhagic Stroke (COADIHS)

Ischemic Stroke | Aneurysmal Subarachnoid Hemorrhage | Haemorrhagic Stroke

Belgium
Hy2Care BV
UMC Utrecht; Avania

Recruiting

Advanced Cartilage Treatment With Injectable-hydrogel Validation of the Effect (ACTIVE)

Cartilage Damage

Netherlands
University Hospital, Bordeaux
Synapse bv

Not yet recruiting

Drug Interactions in Hospital Information System. The PRoSIT System.. (PROSIT)

Drug Interaction

France
ECRI bv
Boston Scientific Corporation

Active, not recruiting

Intravascular Ultrasound Guidance for Complex High-risk Indicated Procedures (IVUS-CHIP)

Complex Coronary Lesions

Spain, United Kingdom, Netherlands, France, Belgium, Germany, Italy
ECRI bv
Micell Technologies; Stentys

Completed

Study Comparing the MiStent SES Versus the XIENCE EES Stent (DESSOLVE III)

Coronary Stenosis

France, Germany, Netherlands, Poland
Amarna Stem Cells BV
Neuroplast

Unknown

Bone Marrow Collection in Healthy Volunteers (iCell) (iCell)

Spinal Cord Injury

Netherlands

Clinical Trials Sponsored by Centocor BV

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Georgia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations